A Case of Best Disease Accompanied by Pachychoroid Neovasculopathy [PDF]
The aim of this case presentation is to describe ocular findings of a 22-year-old patient with Best vitelliform macular dystrophy accompanied by pachychoroid neovasculopathy.
Figen Batıoğlu +4 more
doaj +7 more sources
Multimodal Imaging in Pachychoroid Neovasculopathy: A Case Report [PDF]
Pachychoroid neovasculopathy (PNV) is a form of type 1 neovascularization characterized by dilated choroidal vessels in areas of increased choroidal thickness. In this article, we describe a patient diagnosed with PNV.
Özlem Biçer +3 more
doaj +8 more sources
Efficacy of Intravitreal Brolucizumab Switch in Pachychoroid Neovasculopathy [PDF]
Introduction This study aimed to evaluate the anatomical and functional outcomes of switching to intravitreally administered brolucizumab (Beovu®, Novartis) in patients affected by pachychoroid neovasculopathy (PNV) who were considered as non-responders ...
Nicolò Ribarich +5 more
doaj +5 more sources
Intravitreal Brolucizumab for Pachychoroid Neovasculopathy Associated With Chronic Central Serous Chorioretinopathy [PDF]
To evaluate the anatomical and functional outcomes of intravitreal brolucizumab in eyes with chronic central serous chorioretinopathy complicated by pachychoroid neovasculopathy.Retrospective analysis of 34 eyes treated with intravitreal brolucizumab.
Carosielli, Marianna +9 more
europepmc +6 more sources
The implications of subretinal fluid in pachychoroid neovasculopathy [PDF]
This study aimed to identify the clinical characteristics and longitudinal changes in exudative pachychoroid neovasculopathy (PNV) and non-exudative PNV.
Geun Woo Lee +5 more
doaj +4 more sources
Scleral thickness as a risk factor for central serous chorioretinopathy and pachychoroid neovasculopathy [PDF]
Abstract Background/Objectives. While the exact pathophysiology of pachychoroid disorders remains unclear, scleral changes inducing increased venous outflow resistance are hypothesized to be involved. This work aims to investigate anterior scleral thickness (AST) as a risk factor for central serous chorioretinopathy (CSC) and pachychoroid ...
Leonie F. Keidel +8 more
europepmc +4 more sources
Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration [PDF]
Sufian Elfandi,1 Sotaro Ooto,1 Manabu Miyata,1 Naoko Ueda-Arakawa,1 Yousif Subhi,1,2 Kenji Yamashiro,1 Hiroshi Tamura,1 Akio Oishi,1 Masayuki Hata,1 Nagahisa Yoshimura,1 Akitaka Tsujikawa1 1Department of Ophthalmology and Visual Sciences, Kyoto ...
Elfandi S +10 more
doaj +4 more sources
Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy [PDF]
Pachychoroid neovasculopathy (PNV) is treated with antivascular endothelial growth factor (VEGF) injection and photodynamic therapy (PDT), but no curative treatment has yet been established. We aimed to clarify the treatment results of a reduced dose of PDT for PNV. The subjects were 27 eyes of 27 patients (male:female = 20:7, mean age 58.9 years). PDT,
Koji Tanaka +5 more
europepmc +4 more sources
Pachychoroid neovasculopathy in extramacular choroidal neovascularization
Mrinali Patel Gupta, Irene Rusu, Carly Seidman, Anton Orlin, Donald J D’Amico, Szilard Kiss Department of Ophthalmology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA Purpose: To review a series of extramacular ...
Gupta MP +5 more
doaj +6 more sources
Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration [PDF]
Purpose to determine the percentage of patients with pachychoroid neovasculopathy (PNV) among patients who have been misdiagnosed and treated with wet age-related macular degeneration (AMD).
Mohsen Farvardin +5 more
doaj +4 more sources

